Postmenopausal Women Undergoing Estradiol-Based HT May Have Significantly Decreased Risk For Mortality Due To Vascular Dementia, Study Indicates.

reported, “Postmenopausal women undergoing estradiol-based hormone therapy [HT] have a significantly decreased risk for mortality due to vascular dementia and a modestly decreased risk for mortality due to Alzheimer’s disease,” researchers found after identifying “489,105 Finnish women in a national drug reimbursement register who were using hormone therapy between 1994 and 2009.” The findings were published online in the Journal of Clinical Endocrinology & Metabolism. http://www.endocrinologyadvisor.com/androgen-and-reproductive-disorders/hormone-therapy-and-risk-for-death-from-vascular-dementia/article/578370/